top of page
Published Work
From observational studies to clinical trials, the VIDC research team shares our findings with the medical community at international conferences.
Visit us at an upcoming conference >
Search
2021: A Unique World Hepatitis Day
Hepatitis Can't Wait! VIDC is committed to eliminating viral hepatitis by 2030. Find out how you can join our fight.
Jul 28, 2021
Glecaprevir/pibrentasvir for the treatment of hepatitis C virus infection among active drug users
Glecaprevir/pibrentasvir for the treatment of hepatitis C virus infection among active drug users: the GRAND PLAN study Presented at the...
Feb 28, 2020
Sofosbuvir/velpatasvir (S/V) for the treatment of chronic HCV in active drug users: the CHIME study
Presented at the Canadian Liver Meeting. February 28- March 1, Montreal, Canada, 2020.
Feb 28, 2020
Overdose events among active drug users successfully treated for HCV: the impact of homelessness.
Presented at the Canadian Liver Meeting. February 28- March 1, Montreal, Canada, 2020.
Feb 28, 2020
Glecaprevir/pibrentasvir+sofosbuvir: An optimal retreatment strategy in the setting of HCV NS5A ...
Some individuals do not achieve a cure of their hepatitis C virus (HCV) infection due to non-adherence or resistance associated substitution
Feb 11, 2020
Sofosbuvir and velpatasvir in the treatment of chronic hepatitis C
Advances in hepatitis C virus (HCV) treatment led to the development of highly effective all oral direct acting antiviral regimens.
Dec 16, 2019
Vers l'élimination du VHC en BC : une stratégie pour s'attaquer au 'milieu désordonne'
Présenté à l'International Viral Hepatitis Elimination, 22-23 novembre, Amsterdam, Pays-Bas, 2019
Nov 22, 2019
Efficacité du sofosbuvir/velpatasvir et de l'elbasvir/grazoprevir pour le traitement du VHC de génot
Efficacité du sofosbuvir/velpatasvir et de l'elbasvir/grazoprévir pour le traitement de l'infection par le VHC de génotype 1 dans une...
Nov 8, 2019
Real-World Efficacy of Salvage Therapies for the Treatment of Chronic Hepatitis C Virus Infection...
Real-world efficacy of salvage therapies for the treatment of chronic hepatitis C virus infection in treatment experienced people who...
Nov 8, 2019
Diagnosis and treatment of hepatitis C virus infection: a tool for engagement with people who inject
Vancouver’s Downtown Eastside (DTES) faces the interrelated challenges of poverty, homelessness, mental health, addiction, and medical issue
Jul 17, 2018
bottom of page